Internal Medicine - Issue 9/2014

680
Long-term acting insulin analogues and the risks of hypoglycemic incidence

Alena Adamíková, Jaroslav Rybka

684
Factors causing damage and destruction of beta-cells of the islets of Langerhans in the pancreas

Michal Anděl, Vlasta Němcová, Nela Pavlíková, Jana Urbanová, Marie Čecháková, Andrea Havlová, Radka Straková, Livia Večeřová, Václav Mandys, Jan Kovář, Petr Heneberg, Jan Trnka, Jan Polák

691
Calcium, vitamin D and health

Jaroslav Blahoš, Václav Vyskočil

697
SOLOSTAR study demonstrated high levels of patient satisfaction with the use of the insulin pen SoloStar® in the Czech Republic

Tomáš Edelsberger, Michal Policar, Dita Pospíšilová, Jana Psottová, Jana Houdová, Denisa Janíčková Žďárská

705
News and perspectives in insulin treatment

Martin Haluzík

712
Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice – safety and efficacy in basal bolus regimen)

Denisa Janíčková Žďárská, Jan Brož, Bohumila Křivská, Zdeněk Rušavý, Milan Kvapil

720
AGEs and RAGE – advanced glycation end-products and their receptor in questions and answers

Marta Kalousová, Tomáš Zima

725
Liver, kidneys and diabetes: three faces of HNF1B gene deficit

Jan Lebl, Stanislava Koloušková, Petra Dušátková, Ondřej Cinek, Lenka Dušátková, Tomáš Dědič, Radana Kotalová, Zdeněk Šumník, Tomáš Seeman, Štěpánka Průhová

730
Problems of differential diagnosis of paraneoplastic hypoglycaemia

Marián Mokáň, Peter Galajda

737
Hypoglycemia as a limitation to the treatment of diabetes mellitus

Jindřich Olšovský

742
Changes of bone metabolism in diabetics

Vladimír Palička, Jana Lesná, Ladislava Pavlíková

746
Insulin resistance – its causes and therapy possibilities

Terezie Pelikánová

757
Glycemic variability and continuous monitoring of glycemia

Martin Prázný, Jan Šoupal

765
Life expectancy of people with type 1 diabetes in the past and today

Zdeněk Rušavý, Silvie Lacigová

772
Gliptins: a safe and effective treatment of diabetes mellitus

Jiří Slíva, Martin Prázný

777
How we indicate oral antidiabetics today (from metformin to gliptins and gliflozins)

Štěpán Svačina

782
Receptor pro konečné produkty pokročilé glykace (RAGE) – klíčový hráč diabetické angiopatie?

Jan Škrha Jr, Marta Kalousová, Tomáš Zima

787
Diabetes mellitus and pancreatic cancer – cause or result?

Pavel Škrha

791
Diabetes mellitus and pancreatic cancer – cause or result?

Alena Šmahelová

797
Personalized therapy for diabetes in retrospect and prospect

Ivan Tkáč

801
First fixed dose combination perindopril arginine-indapamide-amlodipine: new approach in combination therapy in hypertension

Jiří Widimský Jr


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account